Outcomes assessed in therapeutic randomised controlled trials in hospitalised patients with COVID-19: Is the meta Core Outcome Set (meta-COS) adopted?

Markus Fally; Alexander G. Mathioudakis; James Wingfield Digby; Paula R. Williamson

doi:10.1016/j.cmi.2021.11.017

Outcomes assessed in therapeutic randomised controlled trials in hospitalised patients with COVID-19: Is the meta Core Outcome Set (meta-COS) adopted?

Markus Fally, Alexander G. Mathioudakis, James Wingfield Digby, Paula R. Williamson

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Letter › peer-review

15 Downloads (Pure)

Original language	English
Journal	Clinical Microbiology and Infection
Early online date	23 Nov 2021
DOIs	https://doi.org/10.1016/j.cmi.2021.11.017
Publication status	Published - 23 Nov 2021

Access to Document

10.1016/j.cmi.2021.11.017

2021_Fally_metaCOSAccepted author manuscript, 3.07 MB

Cite this

@article{692411379a334b408cda16ee62ce4ffd,

title = "Outcomes assessed in therapeutic randomised controlled trials in hospitalised patients with COVID-19: Is the meta Core Outcome Set (meta-COS) adopted?",

author = "Markus Fally and Mathioudakis, {Alexander G.} and {Wingfield Digby}, James and Williamson, {Paula R.}",

year = "2021",

month = nov,

day = "23",

doi = "10.1016/j.cmi.2021.11.017",

language = "English",

journal = "Clinical Microbiology and Infection",